Loading...

FITC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_FITC_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_A_FITC_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_B_FITC_Neg_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
117305 50 µg $54
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117306 500 µg $116
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  2. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  3. Qin S, et al. 2018. Oncol Lett. 128:1283. PubMed
  4. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  5. Pott J et al. 2018. Cell host & microbe. 23(2):191-202 . PubMed
  6. Zhu H, et al. 2018. Elife. 7:. PubMed
  7. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  8. Bi E, et al. 2018. J Clin Invest. 128:4821. PubMed
  9. Bidet K, et al. 2019. NPJ Vaccines. 4:27. PubMed
  10. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  11. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  12. Xue RY, et al. 2019. Front Immunol. 10:1372. PubMed
  13. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  14. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  15. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  16. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  17. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  18. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  19. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  20. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  21. Wan X, et al. 2018. Nature. 560:107. PubMed
  22. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  23. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  24. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  25. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  26. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  27. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  28. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  29. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  30. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  31. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  32. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  33. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  34. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  35. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  36. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  37. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  38. Chin R, et al. 2006. J Immunol. 177:290. PubMed
  39. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  40. Bharali D, et al. 2008. Nanomedicine. 4:311. PubMed
  41. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  42. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  43. Jaiswal M, et al. 2014. J Leukoc Biol. 96:337. PubMed
  44. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  45. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  46. Mizraji* G, et al. 2013. J Vis Exp. 77: 50388. PubMed
  47. Poncini C, et al. 2015. J Immunol. 195: 3311 - 3324. PubMed
  48. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  49. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  50. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  51. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  52. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  53. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  54. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  55. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  56. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  57. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  58. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  59. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  60. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  61. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  62. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  63. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  64. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  65. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  66. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  67. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  68. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  69. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  70. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  71. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  72. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  73. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  74. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  75. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  76. Devenport SN, et al. 2021. JCI Insight. 6: . PubMed
  77. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  78. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  79. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  80. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  81. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  82. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  83. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  84. Gu H, et al. 2021. Elife. 10:. PubMed
  85. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  86. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  87. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  88. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  89. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  90. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  91. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  92. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  93. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  94. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  95. Schwartz AJ, et al. 2021. Nat Metab. 3:969. PubMed
  96. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  97. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  98. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  99. Barrera-Avalos C, et al. 2021. iScience. 24:103520. PubMed
  100. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  101. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  102. Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
  103. Wang X, et al. 2022. Elife. 11:. PubMed
  104. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  105. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  106. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  107. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  108. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  109. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  110. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  111. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  112. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  113. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  114. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  115. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  116. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  117. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  118. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  119. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  120. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  121. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  122. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  123. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  124. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  125. Shen J, et al. 2022. Mater Today Bio. 16:100416. PubMed
  126. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  127. Han W, et al. 2020. J Immunol. 205:1125. PubMed
  128. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  129. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  130. Miki Y, et al. 2022. JCI Insight. 7:. PubMed
  131. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  132. Mao L, et al. 2022. Front Immunol. 13:833418. PubMed
  133. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  136. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  137. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  138. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  139. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  140. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  141. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  142. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  143. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  144. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  145. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  146. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  147. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  148. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  149. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  150. Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed
  151. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  152. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  153. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  154. Li X, et al. 2022. Cell. 185:1709. PubMed
  155. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  156. Li Q, et al. 2022. Biomed Pharmacother. 153:113459. PubMed
  157. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  158. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  159. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  160. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  161. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  162. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  163. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  164. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  165. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  166. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  167. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  168. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
RRID
AB_313774 (BioLegend Cat. No. 117305)
AB_313775 (BioLegend Cat. No. 117306)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account